5 total
Specific performance ordered to enforce settlement agreement after respondent refused to execute purchase documents.
The parties sought to enforce Minutes of Settlement regarding the division and sale of jointly owned commercial properties.
The respondents alleged the applicants breached the agreement by failing to extend a bid deadline during the property auction.
The court found the applicants did not breach the agreement, as the independent broker recommended against the extension and the contract did not require it.
The respondents were found in breach for refusing to execute the backstop purchase agreement without unauthorized amendments.
The court ordered specific performance, compelling the respondents to execute the agreement as drafted.
The court dismissed a motion to stay an action for alleged failure to immediately disclose a partial settlement agreement.
The defendants (other than Johnson Controls) brought a motion to stay the action based on alleged failure by the plaintiff and Johnson Controls to immediately disclose a settlement agreement (the Pro Rata Agreement) that they claimed changed the litigation landscape.
The court dismissed the motion, finding that timely disclosure was made in the context of this particular case and that the agreement did not change the litigation landscape because the action had been effectively stayed and the dispute was being pursued in arbitration.
The court also addressed the application of new Rule 49.14 regarding partial settlement disclosure and fashioned appropriate remedies.
The court declined to appoint an independent chair for a shareholder meeting absent demonstrated impropriety.
The Applicants, Apollo Technology Capital Corporation and Nobul Technologies Inc., sought orders regarding the conduct of the upcoming annual general meeting (AGM) of MediPharm Labs Corp., including the appointment of an independent chair, the appointment of TSX Trust as scrutineer, and a declaration regarding the validity of their Dissident Circular.
The Court declined to grant the requested relief, finding no evidence of impropriety or unfairness in the process established by MediPharm’s by-laws and confirming that the issues raised could be addressed after the AGM if necessary.
Motion for leave to appeal granted.
The plaintiffs brought a motion for leave to appeal Paragraph 22 of the order of Perell J. dated February 11, 2022.
The Divisional Court granted the motion for leave to appeal and directed the parties to arrange a case conference regarding the conduct of the appeal.
Class action settlement and counsel fees approved, but honoraria for representative plaintiffs denied on principle.
The plaintiffs brought a motion for court approval of a $10 million settlement in a certified class action against a ballet school and a former instructor/photographer for alleged sexual assault and privacy breaches.
The plaintiffs also sought approval of Class Counsel's fees and honoraria for the representative plaintiffs and certain class members.
The court approved the settlement as fair, reasonable, and in the best interests of the class, and approved Class Counsel's fee request of $2.25 million.
However, the court declined to approve the requested honoraria, holding on principle that the practice of awarding a stipend to representative plaintiffs for prosecuting a civil claim is contrary to the administration of justice and should be stopped.